RESUMO
Background: There are limited global data on head-to-head comparisons of vaccine platforms assessing both humoral and cellular immune responses, stratified by pre-vaccination serostatus. The COVID-19 vaccination drive for the Indian population in the age group 18-45 years began in April 2021 when seropositivity rates in the general population were rising due to the delta wave of COVID-19 pandemic during April-May 2021. Methods: Between June 30, 2021, and Jan 28, 2022, we enrolled 691 participants in the age group 18-45 years across four clinical sites in India. In this non-randomised and laboratory blinded study, participants received either two doses of Covaxin® (4 weeks apart) or two doses of Covishield™ (12 weeks apart) as per the national vaccination policy. The primary outcome was the seroconversion rate and the geometric mean titre (GMT) of antibodies against the SARS-CoV-2 spike and nucleocapsid proteins post two doses. The secondary outcome was the frequency of cellular immune responses pre- and post-vaccination. Findings: When compared to pre-vaccination baseline, both vaccines elicited statistically significant seroconversion and binding antibody levels in both seronegative and seropositive individuals. In the per-protocol cohort, Covishield™ elicited higher antibody responses than Covaxin® as measured by seroconversion rate (98.3% vs 74.4%, p < 0.0001 in seronegative individuals; 91.7% vs 66.9%, p < 0.0001 in seropositive individuals) as well as by anti-spike antibody levels against the ancestral strain (GMT 1272.1 vs 75.4 binding antibody units/ml [BAU/ml], p < 0.0001 in seronegative individuals; 2089.07 vs 585.7 BAU/ml, p < 0.0001 in seropositive individuals). As participants at all clinical sites were not recruited at the same time, site-specific immunogenicity was impacted by the timing of vaccination relative to the delta and omicron waves. Surrogate neutralising antibody responses against variants-of-concern including delta and omicron was higher in Covishield™ recipients than in Covaxin® recipients; and in seropositive than in seronegative individuals after both vaccination and asymptomatic infection (omicron variant). T cell responses are reported from only one of the four site cohorts where the vaccination schedule preceded the omicron wave. In seronegative individuals, Covishield™ elicited both CD4+ and CD8+ spike-specific cytokine-producing T cells whereas Covaxin® elicited mainly CD4+ spike-specific T cells. Neither vaccine showed significant post-vaccination expansion of spike-specific T cells in seropositive individuals. Interpretation: Covishield™ elicited immune responses of higher magnitude and breadth than Covaxin® in both seronegative individuals and seropositive individuals, across cohorts representing the pre-vaccination immune history of most of the vaccinated Indian population. Funding: Corporate social responsibility (CSR) funding from Hindustan Unilever Limited (HUL) and Unilever India Pvt. Ltd. (UIPL).
RESUMO
Feathers, rich in keratin, are usually the unused by-products of poultry industries. In addition, the cast-off X-ray films serve as secondary sources of silver, and the traditional method of silver extraction from this source is costly and not eco-friendly. Therefore, the current study focuses on protease production using a freshwater bacterium Chryseobacterium cucumeris SARJS-2, aiming to convert these wastes into useful products. The protease production was optimized by one-factor-at-a-time (OFAT), followed by Plackett Burman design (PBD) and response surface methodology (RSM). The protease production got enhanced by more than two folds after the statistical optimisation. Upon partial purification, the enzyme activity increased by approximately three folds. The protease was active in the range of temperatures from 25 to 75 °C, but the optimum temperature was recorded as 35 °C. The protease exhibited detergent compatibility and organic solvent stability. The detergent compatibility suggests the protease could be a detergent additive. It was also found that the presence of Fe+2 enhanced protease activity. The protease was tested for stain removal, feather degradation and silver recovery applications. It was found that the protease could efficiently remove stains of blood and tomato sauce. In addition, the protease was found to be a successful candidate for feather degradation, thereby feather-hydrolysate production which has prominent roles as nature-friendly fertilizer and animal feed ingredient. The protease also degraded gelatin from the X-ray films to release the silver-halides for silver recovery. The results recommend that the SARJS-2 protease is a potential candidate for use in eco-friendly applications in various industrial sectors.
RESUMO
Bacterial cellulose (BC) is an excellent natural biopolymer with wide range of applications. The present study reports a potential BC producing thermophile, identified as Bacillus licheniformis strain ZBT2. The thermophile produced pellicle form of BC (3.0 g/l) under static conditions. Statistical optimization of BC was carried out by Plackett-Burman and central composite design. Results suggest that BC yield (9.2 g/l) was enhanced with 6.6-fold after optimization. BC-gelatin hydrogels composites were developed to assess various properties. The water retention capability and moisture content properties of BC and composites were promising and also exhibited negligible protein adsorption. The composites also demonstrated to be consistent during controlled drug delivery profiling. Furthermore, the composites also demonstrated antibacterial efficiency against Escherichia coli and Micrococcus luteus. The structural, morphological and thermal properties were assessed by analytical techniques such as, fourier transform infrared spectroscopy, scanning electron microscopy with energy dispersive X-ray analysis, thermogravimetric analysis and differential scanning calorimetry analysis. The study reflects the exploitation of a thermophile for development of BC which can be a preferred choice as a scaffold for tissue engineering and drug-delivery systems.
